Fast, Accurate and Portable Molecular Analyzer to Revolutionize Diagnostics
By LabMedica International staff writers Posted on 03 Sep 2022 |
The increase in the prevalence of infectious diseases and the onset of the COVID-19 pandemic has led to an increase in lab testing in order to keep pace with rising cases across the world. However, traditional lab-based tests can take days to weeks for results. Now, a fast, accurate, and portable DNA analyzer goes from sample to result in approximately an hour and delivers quality results outside of a lab.
Genomadix Inc.’s (Kanata, ON, Canada) Genomadix Cube is a portable, molecular analyzer that uses polymerase chain reaction (PCR) technology to generate relatively quick, accurate test results, outside of a healthcare facility. Designed to be used as a decentralized testing option, the analyzer is especially helpful for remote communities and remote industries where access to a full lab may be difficult. Samples are collected and inserted into a single-use DNA test cartridge. Inside the analyzer, the cartridge extracts the DNA/RNA and makes millions of copies based on PCR. An optical system detects the increased fluorescence and algorithms automatically generate a test result.
The Genomadix Cube automates complex and tedious manual procedures, advancing sample to result DNA/RNA testing in clinical, environmental, infectious disease, and precision medicine. The testing system already delivers environmental testing for potentially deadly Legionella bacteria in water sources such as building cooling towers and CYP2C19 genotype guided antiplatelet therapy in Europe with efforts underway for US authorization. Additionally, a COVID-19 product has been developed with introduction slated (pending authorization) for later in 2022. These tests are run using their own unique software on the Genomadix Cube.
Related Links:
Genomadix Inc.
Latest Molecular Diagnostics News
- Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans